Axcella Health Inc. - Common Stock (NQ:AXLA)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Nov 22, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Axcella Health Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Benzinga's Top Ratings Upgrades, Downgrades For July 30, 2021 ↗

July 30, 2021

Upgrades According to Craig-Hallum, the prior rating for Gentherm Inc (NASDAQ:

Via Benzinga

Axcella Reports Second Quarter Financial Results and Provides Business Update

July 29, 2021

From Axcella

Via Business Wire

Axcella to Report Second Quarter 2021 Financial Results on July 29, 2021

July 22, 2021

From Axcella

Via Business Wire

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

61 Biggest Movers From Yesterday ↗

July 08, 2021

Gainers Newegg Commerce, Inc. (NASDAQ: NEGG) shares surged 148.4% to close at $67.57 on Wednesday after jumping around 42% on Tuesday. Mannatech, Incorporated (NASDAQ: MTEX)...

Via Benzinga

42 Stocks Moving In Tuesday's Mid-Day Session ↗

July 06, 2021

Gainers Orbsat Corp. (NASDAQ: OSAT) shares jumped 74% to $9.47. BSQUARE Corporation (NASDAQ: BSQR) shares jumped 48.2% to $5.90 after dropping around 10% on Friday. Bridgeline...

Via Benzinga

61 Biggest Movers From Yesterday ↗

July 07, 2021

Gainers BSQUARE Corporation (NASDAQ: BSQR) shares climbed 77.1% to close at $7.05 on Tuesday on abnormally-high volume. The company’s stock dropped around 10% on Friday....

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2021 ↗

July 06, 2021

Upgrades According to Citigroup, the prior rating for ORIC Pharmaceuticals Inc (NASDAQ:

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 06, 2021

Gainers Advaxis (NASDAQ:ADXS) stock rose 46.9% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $100.9 million. Axcella...

Via Benzinga

Axcella Announces Initiation of EMMPOWER℠ Phase 2 Clinical Trial of AXA1665

June 30, 2021

From Axcella

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 11, 2021

Gainers GBS (NASDAQ:GBS) stock increased by 41.04% to $5.12 during Friday's pre-market session. Novan (NASDAQ:NOVN) stock increased by 36.5% to $12.34. The company...

Via Benzinga

28 Stocks Moving in Friday's Pre-Market Session ↗

June 11, 2021

Gainers Amesite Inc. (NASDAQ: AMST) rose 138% to $6.60 in pre-market trading after surging over 25% on Thursday. Chemomab Therapeutics Ltd. (NASDAQ: CMMB) rose 37.5% to $27.50...

Via Benzinga

66 Biggest Movers From Yesterday ↗

June 11, 2021

Gainers Orphazyme A/S (NASDAQ: ORPH) shares jumped 302.3% to close at $21.00 on Thursday. Shares of the biopharmaceutical firm touched an intraday high of $77.77, running up 1,...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 10, 2021

Gainers Tyme Technologies (NASDAQ:TYME) s...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 10, 2021

Gainers NuCana (NASDAQ:NCNA) shares moved upwards by 16.17% to $3.16 during Thursday's regular session. NuCana's stock is trading at a volume of 4.7 million shares...

Via Benzinga

The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs ↗

May 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB)...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 26, 2021

Wednesday morning, 20 companies set new 52-week lows. Interesting Facts: The largest company in terms of market cap to set a new 52-week low was Ionis...

Via Benzinga

The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing ↗

May 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 25) ESSA Pharma Inc. (NASDAQ:...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

May 25, 2021

Tuesday's morning session saw 16 companies set new 52-week lows. Noteworthy Points: The largest company in terms of market cap to set a new 52-week low was...

Via Benzinga

Positive Clinical Data About Axcella’s AXA1665 Candidate for Overt Hepatic Encephalopathy Highlighted in Oral Presentation at DDW 2021

May 24, 2021

From Axcella

Via Business Wire

Axcella Announces Initiation of EMMPACT℠ Phase 2b Clinical Trial of AXA1125

May 11, 2021

From Axcella

Via Business Wire

Axcella Announces Initiation of EMMPACTSM Phase 2b Clinical Trial of AXA1125

May 11, 2021

From Axcella

Via Business Wire

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗

May 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...

Via Benzinga

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings ↗

May 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

May 10, 2021

Monday morning saw 78 companies set new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Rocket Companies (NYSE:RKT)....

Via Benzinga

Axcella Reports First Quarter Financial Results and Provides Business Update

May 06, 2021

From Axcella

Via Business Wire

The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs ↗

May 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Axcella to Report First Quarter 2021 Financial Results on May 6, 2021

April 27, 2021

From Axcella

Via Business Wire

Axcella Announces Upcoming Oral Presentation at Digestive Disease Week (DDW) 2021

April 22, 2021

From Axcella

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.